{"product_id":"exactsciences-business-model-canvas","title":"Exact Sciences Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInvestor-ready Business Model Canvas for a leading molecular diagnostics innovator\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Exact Sciences's Business Model Canvas. This in-depth map shows how the company creates value through innovative diagnostics, commercial partnerships, and diversified revenue streams while spotlighting competitive advantages and key risks. Purchase the complete, editable canvas for section-by-section insights ideal for investor decks, strategic planning, or benchmarking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayer and insurer alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eReimbursement agreements with Medicare (coverage since 2014) and payers covering over 90% of commercial lives ensure broad access to Cologuard and precision oncology tests. These partnerships lower patient out-of-pocket costs and accelerate adoption. Joint value dossiers and outcomes data drive favorable policies, while multiyear payer contracts improve revenue visibility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare provider networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrimary care (about 70% of screening referrals), GI specialists and oncology clinics serve as critical referral sources for Exact Sciences tests. Co-developed clinical pathways with health systems and networks embed tests into standard care across hundreds of organizations. Targeted clinician education and streamlined sample logistics reduce ordering friction and speed result delivery. Key opinion leaders accelerate evidence adoption and drive guideline inclusion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaboratory and logistics partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eExact Sciences leverages CLIA-certified labs and high-throughput partners to scale testing quality within the ~100 billion USD US clinical lab market in 2024, while cold-chain and courier networks ensure reliable sample transport. Integrated LIMS and interoperability trim turnaround times, and capacity partners enable spikes in demand and new-test launches.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch institutions and biopharma\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eResearch centers supply cohorts, biobanks and trial sites to validate biomarkers, enabling Exact Sciences to link diagnostics to targeted therapies with biopharma partners; in 2024 Exact Sciences reported roughly $3.3B revenue, supporting expanded RWE programs that strengthened clinical utility claims and yielded co-publications boosting credibility.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAcademic cohorts and biobanks\u003c\/li\u003e\n\u003cli\u003eBiopharma companion diagnostics\u003c\/li\u003e\n\u003cli\u003eRWE studies (2024 scale-up)\u003c\/li\u003e\n\u003cli\u003eCo-publications increase adoption\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and advocacy collaborations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEngagement with FDA, CMS, and guideline bodies aligns test development and reimbursement, leveraging Medicare coverage of Cologuard for beneficiaries 50–85 every 3 years. Patient advocacy groups such as American Cancer Society amplify awareness and adherence. Public health and policy partnerships drive population screening and support USPSTF screening guidance for ages 45–75.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMedicare coverage: beneficiaries 50–85 every 3 years\u003c\/li\u003e\n\u003cli\u003eUSPSTF: screening 45–75\u003c\/li\u003e\n\u003cli\u003eAdvocacy: ACS partnership\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare coverage, payer reach \u003cstrong\u003e\u0026gt;90%\u003c\/strong\u003e, primary care referrals \u003cstrong\u003e~70%\u003c\/strong\u003e, 2024 revenue \u003cstrong\u003e$3.3B\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eReimbursement deals (Medicare coverage since 2014; payers cover \u0026gt;90% commercial lives) and multiyear contracts drive access and revenue visibility. Referral partnerships (primary care ~70% of screening referrals) and health systems embed Cologuard into care. CLIA labs, couriers and biopharma RWE alliances scaled capacity—2024 revenue ~$3.3B.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$3.3B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS lab market\u003c\/td\u003e\n\u003ctd\u003e$100B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCommercial lives covered\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrimary care referrals\u003c\/td\u003e\n\u003ctd\u003e~70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas tailored to Exact Sciences that maps its nine core blocks—value propositions, customer segments, channels, revenue streams, key resources, activities, partners, cost structure, and customer relationships—against real-world diagnostics and molecular screening operations. Includes competitive advantages, SWOT-linked insights, and polished narratives ideal for investor presentations and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level, editable Business Model Canvas for Exact Sciences that condenses its diagnostic and screening strategy into a one-page snapshot, saving hours of structuring while enabling quick comparisons, team collaboration, and fast deliverables for boardrooms or analysts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAssay R\u0026amp;D and biomarker discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eContinuous innovation across multi-target stool DNA (Cologuard), blood-based, and tissue assays drives Exact Sciences pipeline expansion; Cologuard showed 92% sensitivity and 87% specificity for colorectal cancer in pivotal validation.\u003c\/p\u003e\n\u003cp\u003eRigorous analytical validation programs confirm sensitivity and specificity benchmarks for each assay.\u003c\/p\u003e\n\u003cp\u003eAdvanced bioinformatics refines molecular signatures from large clinical datasets, while a growing IP portfolio secures competitive advantage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical trials and evidence generation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProspective DeeP-C trial showed Cologuard sensitivity for colorectal cancer 92.3% and specificity 89.8%. Retrospective and real-world studies corroborate clinical validity and utility. Health-economics models demonstrate cost-effectiveness versus no screening; USPSTF 2021 included stool-based tests and CMS covers Cologuard for Medicare beneficiaries every 3 years.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and lab operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh-throughput sample processing at Exact Sciences handles over 1 million clinical samples annually (2024), delivering reliable 24–72 hour turnaround for most workflows. Quality systems keep operations CLIA- and CAP-compliant across their clinical labs. Automation and robotics have improved yield and reduced analytical errors by roughly 30% while boosting throughput above 10,000 samples per day. Capacity planning and flexible shifts enable scaling for seasonality and demand spikes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial sales and medical education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMulti-channel field teams engage providers and payers to drive adoption and reimbursement for screening products; medical science liaisons disseminate peer-reviewed data to clinicians and institutions to support guideline inclusion. Patient outreach programs increase screening completion rates while digital campaigns bolster adherence and timely re-screening.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eField teams: provider \u0026amp; payer engagement\u003c\/li\u003e\n\u003cli\u003eMSLs: peer-reviewed data dissemination\u003c\/li\u003e\n\u003cli\u003ePatient outreach: screening completion\u003c\/li\u003e\n\u003cli\u003eDigital campaigns: adherence \u0026amp; re-screening\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData integration and informatics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eData integration and informatics enable interoperability with EHRs and e-ordering to simplify clinician workflows, leveraging the fact that 96% of US hospitals use certified EHRs (ONC). Centralized data warehouses consolidate clinical and operational metrics, while AI risk-stratification models improve test performance and secure analytics support payer and provider reporting.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInteroperability: EHR integration (96% hospital EHR adoption)\u003c\/li\u003e\n\u003cli\u003eConsolidation: centralized data warehouses for metrics\u003c\/li\u003e\n\u003cli\u003eAI: enhanced risk stratification and test accuracy\u003c\/li\u003e\n\u003cli\u003eReporting: secure analytics for payers\/providers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAssay R\u0026amp;D boosts screening: 92.3% sens \/ 89.8% spec, 24–72h TAT\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAssay R\u0026amp;D (Cologuard, blood\/tissue) drives pipeline; DeeP-C Cologuard sensitivity 92.3% \/ specificity 89.8%, CMS covers every 3 years. Labs processed \u0026gt;1,000,000 samples in 2024 with 24–72h TAT, CLIA\/CAP; automation cut errors ~30% and supports \u0026gt;10,000\/day. Field teams, MSLs, EHR integration (96% hospital EHR adoption) and AI enable adoption and payer reporting.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSamples processed\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCologuard Sens\/Spec\u003c\/td\u003e\n\u003ctd\u003e92.3% \/ 89.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTAT\u003c\/td\u003e\n\u003ctd\u003e24–72h\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThroughput\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;10,000\/day\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEHR adoption\u003c\/td\u003e\n\u003ctd\u003e96%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe Business Model Canvas for Exact Sciences shown here is the actual deliverable, not a mockup. When you purchase, you’ll receive this same complete document—fully formatted and editable. Files are provided ready to use for analysis, presentation, and sharing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56161444528505,"sku":"exactsciences-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/exactsciences-business-model-canvas.png?v=1762693175","url":"https:\/\/portersfiveforce.com\/products\/exactsciences-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}